Literature DB >> 20820744

Intracellular trafficking of silicon particles and logic-embedded vectors.

Silvia Ferrati1, Aaron Mack, Ciro Chiappini, Xuewu Liu, Andrew J Bean, Mauro Ferrari, Rita E Serda.   

Abstract

Mesoporous silicon particles show great promise for use in drug delivery and imaging applications as carriers for second-stage nanoparticles and higher order particles or therapeutics. Modulation of particle geometry, surface chemistry, and porosity allows silicon particles to be optimized for specific applications such as vascular targeting and avoidance of biological barriers commonly found between the site of drug injection and the final destination. In this study, the intracellular trafficking of unloaded carrier silicon particles and carrier particles loaded with secondary iron oxide nanoparticles was investigated. Following cellular uptake, membrane-encapsulated silicon particles migrated to the perinuclear region of the cell by a microtubule-driven mechanism. Surface charge, shape (spherical and hemispherical) and size (1.6 and 3.2 microm) of the particle did not alter the rate of migration. Maturation of the phagosome was associated with an increase in acidity and acquisition of markers of late endosomes and lysosomes. Cellular uptake of iron oxide nanoparticle-loaded silicon particles resulted in sorting of the particles and trafficking to unique destinations. The silicon carriers remained localized in phagosomes, while the second stage iron oxide nanoparticles were sorted into multi-vesicular bodies that dissociated from the phagosome into novel membrane-bound compartments. Release of iron from the cells may represent exocytosis of iron oxide nanoparticle-loaded vesicles. These results reinforce the concept of multi-functional nanocarriers, in which different particles are able to perform specific tasks, in order to deliver single- or multi-component payloads to specific sub-cellular compartments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820744      PMCID: PMC2936484          DOI: 10.1039/c0nr00227e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  21 in total

1.  Efficient active transport of gene nanocarriers to the cell nucleus.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

Review 2.  Endothelial endocytic pathways: gates for vascular drug delivery.

Authors:  Silvia Muro; Michael Koval; Vladimir Muzykantov
Journal:  Curr Vasc Pharmacol       Date:  2004-07       Impact factor: 2.719

3.  Mitotic trafficking of silicon microparticles.

Authors:  Rita E Serda; Silvia Ferrati; Biana Godin; Ennio Tasciotti; XueWu Liu; Mauro Ferrari
Journal:  Nanoscale       Date:  2009-10-05       Impact factor: 7.790

Review 4.  Cancer nanotechnology: opportunities and challenges.

Authors:  Mauro Ferrari
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

5.  Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH.

Authors:  N Fang; V Chan; H Q Mao; K W Leong
Journal:  Biomacromolecules       Date:  2001       Impact factor: 6.988

6.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

Authors:  R M Sawant; J P Hurley; S Salmaso; A Kale; E Tolcheva; T S Levchenko; V P Torchilin
Journal:  Bioconjug Chem       Date:  2006 Jul-Aug       Impact factor: 4.774

7.  A role for microtubule dynamics in phagosome movement.

Authors:  A Blocker; G Griffiths; J C Olivo; A A Hyman; F F Severin
Journal:  J Cell Sci       Date:  1998-02       Impact factor: 5.285

8.  Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

9.  Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery.

Authors:  Jayanth Panyam; Wen-Zhong Zhou; Swayam Prabha; Sanjeeb K Sahoo; Vinod Labhasetwar
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

10.  Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP.

Authors:  Rene E Harrison; Cecilia Bucci; Otilia V Vieira; Trina A Schroer; Sergio Grinstein
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more
  24 in total

1.  A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.

Authors:  Bronwyn Scott; Jianliang Shen; Sara Nizzero; Kathryn Boom; Stefano Persano; Yu Mi; Xuewu Liu; Yuliang Zhao; Elvin Blanco; Haifa Shen; Mauro Ferrari; Joy Wolfram
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

2.  Evaluation of cell function upon nanovector internalization.

Authors:  Jonathan O Martinez; Alessandro Parodi; Xuewu Liu; Mikhail G Kolonin; Mauro Ferrari; Ennio Tasciotti
Journal:  Small       Date:  2012-11-20       Impact factor: 13.281

3.  Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system.

Authors:  Enrica De Rosa; Ciro Chiappini; Dongmei Fan; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Pharm Res       Date:  2011-05-24       Impact factor: 4.200

4.  Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.

Authors:  Jonathan O Martinez; Christian Boada; Iman K Yazdi; Michael Evangelopoulos; Brandon S Brown; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Small       Date:  2012-12-16       Impact factor: 13.281

Review 5.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

6.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Authors:  Alessandro Parodi; Nicoletta Quattrocchi; Anne L van de Ven; Ciro Chiappini; Michael Evangelopoulos; Jonathan O Martinez; Brandon S Brown; Sm Z Khaled; Iman K Yazdi; Maria Vittoria Enzo; Lucas Isenhart; Mauro Ferrari; Ennio Tasciotti
Journal:  Nat Nanotechnol       Date:  2012-12-16       Impact factor: 39.213

7.  Dual-imaging enabled cancer-targeting nanoparticles.

Authors:  Aniket S Wadajkar; Tejaswi Kadapure; Yi Zhang; Weina Cui; Kytai T Nguyen; Jian Yang
Journal:  Adv Healthc Mater       Date:  2012-07       Impact factor: 9.933

8.  A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics.

Authors:  Guillermo U Ruiz-Esparza; Victor Segura-Ibarra; Andrea M Cordero-Reyes; Keith A Youker; Rita E Serda; Ana S Cruz-Solbes; Javier Amione-Guerra; Kenji Yokoi; Dickson K Kirui; Francisca E Cara; Jesus Paez-Mayorga; Jose H Flores-Arredondo; Carlos E Guerrero-Beltrán; Gerardo Garcia-Rivas; Mauro Ferrari; Elvin Blanco; Guillermo Torre-Amione
Journal:  Eur J Heart Fail       Date:  2016-01-07       Impact factor: 15.534

9.  Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.

Authors:  Tomonori Tanei; Fransisca Leonard; Xuewu Liu; Jenolyn F Alexander; Yuki Saito; Mauro Ferrari; Biana Godin; Kenji Yokoi
Journal:  Cancer Res       Date:  2016-01-07       Impact factor: 12.701

10.  The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Vivek Karun; Evan Shegog; Joshua A Wang; Christian Boada; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.